This protocol is judged by an institutional evaluate board, an independent team that critiques any scientific trials involving individuals. If a review requires a Schedule I drug, as soon as the board approves the protocol as ethical, the scientists need to apply for an investigational new drug (IND) quantity with the FDA.Loads of social networking